[PHARMA] YoY Quarter Result on 31-Mar-2017 [#1]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
16-May-2017
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2017
Quarter
31-Mar-2017 [#1]
Profit Trend
QoQ- 2363.52%
YoY- 2.96%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Revenue 819,921 786,108 617,923 618,294 559,195 471,904 468,672 9.76%
PBT 30,880 30,243 28,707 27,777 26,538 38,612 38,159 -3.46%
Tax -8,465 -10,595 -11,118 -8,519 -8,068 -6,686 -11,513 -4.99%
NP 22,415 19,648 17,589 19,258 18,470 31,926 26,646 -2.83%
-
NP to SH 22,399 19,617 17,586 18,923 18,379 31,794 26,217 -2.58%
-
Tax Rate 27.41% 35.03% 38.73% 30.67% 30.40% 17.32% 30.17% -
Total Cost 797,506 766,460 600,334 599,036 540,725 439,978 442,026 10.32%
-
Net Worth 350,047 528,825 524,838 544,360 515,906 528,173 515,022 -6.22%
Dividend
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Div 15,673 15,630 12,991 10,368 10,354 18,123 10,352 7.15%
Div Payout % 69.98% 79.68% 73.87% 54.79% 56.34% 57.00% 39.49% -
Equity
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Net Worth 350,047 528,825 524,838 544,360 515,906 528,173 515,022 -6.22%
NOSH 261,229 260,505 259,821 259,219 258,859 258,908 258,805 0.15%
Ratio Analysis
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
NP Margin 2.73% 2.50% 2.85% 3.11% 3.30% 6.77% 5.69% -
ROE 6.40% 3.71% 3.35% 3.48% 3.56% 6.02% 5.09% -
Per Share
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
RPS 313.87 301.76 237.83 238.52 216.02 182.27 181.09 9.59%
EPS 8.57 7.53 6.77 7.30 7.10 12.28 10.13 -2.74%
DPS 6.00 6.00 5.00 4.00 4.00 7.00 4.00 6.98%
NAPS 1.34 2.03 2.02 2.10 1.993 2.04 1.99 -6.37%
Adjusted Per Share Value based on latest NOSH - 259,219
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
RPS 56.89 54.54 42.87 42.90 38.80 32.74 32.52 9.75%
EPS 1.55 1.36 1.22 1.31 1.28 2.21 1.82 -2.63%
DPS 1.09 1.08 0.90 0.72 0.72 1.26 0.72 7.14%
NAPS 0.2429 0.3669 0.3642 0.3777 0.358 0.3665 0.3573 -6.22%
Price Multiplier on Financial Quarter End Date
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Date 31/03/20 29/03/19 30/03/18 31/03/17 31/03/16 31/03/15 31/03/14 -
Price 1.26 2.27 4.28 4.89 5.76 6.00 4.46 -
P/RPS 0.40 0.75 1.80 2.05 2.67 3.29 2.46 -26.10%
P/EPS 14.69 30.14 63.23 66.99 81.13 48.86 44.03 -16.70%
EY 6.81 3.32 1.58 1.49 1.23 2.05 2.27 20.07%
DY 4.76 2.64 1.17 0.82 0.69 1.17 0.90 31.96%
P/NAPS 0.94 1.12 2.12 2.33 2.89 2.94 2.24 -13.46%
Price Multiplier on Announcement Date
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Date 19/05/20 16/05/19 16/05/18 16/05/17 13/05/16 18/05/15 14/05/14 -
Price 1.88 2.36 4.07 4.72 5.60 6.91 4.70 -
P/RPS 0.60 0.78 1.71 1.98 2.59 3.79 2.60 -21.66%
P/EPS 21.93 31.34 60.13 64.66 78.87 56.27 46.40 -11.73%
EY 4.56 3.19 1.66 1.55 1.27 1.78 2.16 13.24%
DY 3.19 2.54 1.23 0.85 0.71 1.01 0.85 24.63%
P/NAPS 1.40 1.16 2.01 2.25 2.81 3.39 2.36 -8.32%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment